BIN1 and neoplasm: In particular, aberrant splicing of a brain-specific exon (exon 12A, Figure 4) in malignant cells can abolish the tumor-suppressor activity of BIN1 by interfering with MYC binding [77], which is regulated by phosphorylation of MYC at Ser62 [86].